LivaNova Announces Pricing of Private Offering of $300 Million of 2.50% Convertible Senior Notes Due 2029Business Wire • 03/06/24
LivaNova Announces Proposed Private Offering of $300 Million of Convertible Senior NotesBusiness Wire • 03/04/24
LivaNova Announces Marco Dolci, President of Cardiopulmonary, to Retire at the End of 2023Business Wire • 09/21/23
LivaNova Unveils Essenz In-Line Blood Monitor with U.S. FDA 510(k) Clearance and CE MarkBusiness Wire • 08/30/23
LivaNova Announces 150th Bipolar Depression Patient Randomized in RECOVER Clinical StudyBusiness Wire • 06/13/23